Tema Neuroscience and Mental Health ETF (MNTL)

Assets	$9.37M
Expense Ratio	0.75%
PE Ratio	22.18
Shares Out	440,000
Dividend (ttm)	$0.26
Dividend Yield	1.18%
Ex-Dividend Date	Dec 11, 2024
Payout Ratio	26.07%
1-Year Return	-8.44%

Volume	n/a
Open	n/a
Previous Close	21.32
Day's Range	n/a
52-Week Low	19.86
52-Week High	27.66
Beta	n/a
Holdings	48
Inception Date	Jan 22, 2024

About MNTL

Fund Home Page

The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: MNTL
• ETF Provider: Tema

Top 10 Holdings

53.26% of assets

Name	Symbol	Weight
Vertex Pharmaceuticals Incorporated	VRTX	11.71%
Regeneron Pharmaceuticals, Inc.	REGN	7.69%
argenx SE	ARGX	5.66%
Alnylam Pharmaceuticals, Inc.	ALNY	4.92%
Eli Lilly and Company	LLY	4.78%
Crinetics Pharmaceuticals, Inc.	CRNX	4.20%
Neurocrine Biosciences, Inc.	NBIX	4.19%
Teva Pharmaceutical Industries Limited	TEVA	4.10%
Biogen Inc.	BIIB	3.11%
Stryker Corporation	SYK	2.89%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 11, 2024	$0.25697	Dec 12, 2024